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ABSTRACT
Background: Since the performance of the first laparo-
scopic cardiomyotomy for achalasia cardia in 1991, the
popularity of the minimally invasive approach for this
troublesome disease has been growing. We present our
experience of 226 patients who underwent laparoscopic
cardiomyotomy and discuss the relevant issues.
Methods: A retrospective analysis was carried out of 226
patients who have undergone laparoscopic cardiomyo-
tomy since 1993. The preoperative workup, surgical tech-
nique, and postoperative management are described.
Results: Patients included 146 males and 80 females;
average age was 36.4 years (range, 6 to 85). Mean duration
of symptoms was 1.4 years. Nearly half of the patients
(112) had undergone prior pneumatic dilatation. In 20
patients, myotomy alone was done, 44 patients had a
Dor’s fundoplication, and 162 had Toupet’s fundoplica-
tion. The average operating time was 96 minutes. Mean
postoperative hospital stay was 2.2 days. Dysphagia was
eliminated in 88.9% of the patients with an overall mor-
bidity of 4.4% and nil mortality over a mean follow-up of
4.3 years.
Conclusion: Laparoscopic cardiomyotomy with Toupet’s
fundoplication is a safe and effective treatment of achala-
sia cardia. Dor’s fundoplication is done selectively, espe-
cially when suspicion is present of mucosal injury.
Key Words: Achalasia cardia, Laparoscopic cardiomyo-
tomy, Toupet’s fundoplication, Dor’s fundoplication.
INTRODUCTION
For nearly 250 years, achalasia cardia was known as car-
diospasm, a misnomer for a disease wherein the lower
esophageal sphincter (LES) is not in spasm but fails to
relax. More than 300 years ago, Sir Thomas Willis de-
scribed a patient suffering from dysphagia, which he de-
duced to be due to obstruction at the cardia. In 1672, he
treated the patient by dilation using a sponge attached to
a whalebone, thus recording the first successful treatment
of this disease.1 Over the years, the cause of this puzzling
disease remained a mystery and, by consensus, it came to
be known by the generic name of cardiospasm. Finally, in
1927, Sir Arthur Hurst2 coined the term achalasia after
demonstrating the failure of the LES to relax normally.
Ernest Heller,3 a German, did the first successful esoph-
agomyotomy 241 years later on April 14, 1913. He de-
scribed both anterior and posterior myotomy. In 1923,
Zaaijer4 modified the procedure by performing a single
anterior myotomy, achieving the same successful results
with reduced morbidity. The arrival of minimally invasive
techniques in this field was heralded by the reports of
Shimi et al5 describing laparoscopic approach in 1991 and
Pellegrini6 describing the thoracoscopic approach in 1992.
After this, several studies7–9 have reported good results
with laparoscopic cardiomyotomy.
We present our experience with laparoscopic cardiomyo-
tomy in 226 patients. Our aim is to describe our technique,
especially our use of the modified pericardiomyotomy
scissors, present our results, and assess the effectiveness
of laparoscopic cardiomyotomy.
METHODS
This is a retrospective analysis of 226 patients who have
undergone laparoscopic cardiomyotomy since 1993 in our
center. Preoperative workup included clinical evaluation,
routine hematological tests, upper GI endoscopy, barium
swallow, and manometry. On the night before surgery, a
14G Ryle’s tube is inserted, and a wash is given with
normal saline until the returning fluid is clear. After this,
the patient is posted for surgery.
The procedure is carried out with the patient in the mod-
ified Lloyd Davies position such that the thighs are parallel
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SCIENTIFIC PAPERto the ground and a reverse Trendelenburg is approxi-
mately 30 degrees. The patient position and the position
of the personnel are depicted in Figure 1. After creating
the pneumoperitoneum, the trocars are placed as shown
in Figure 2. A 30-degree scope is placed through the
supraumbilical port. The left lobe of the liver is lifted up
by a blunt-tipped instrument inserted through the subxi-
phoid trocar. The stomach is retracted caudally through
the left anterior axillary port. The tenuous window of
Kustner is divided, and the right crus is identified. The
crus is dissected from the esophagus, the peritoneum and
phrenoesophageal membrane are divided, and the left
crus is identified. For the patient undergoing a Dor fun-
doplication, the mobilization is limited to the lateral and
anterior aspects. The anterior vagus nerve is identified and
protected during the course of the dissection. The proxi-
mal esophagus is dissected for a distance of about 2cm to
3cm into the dilated segment of the esophagus in the
posterior mediastinum.
Myotomy is carried out over the left side of the anterior
aspect of the esophagus, beginning 1cm to 2cm cranial to
the cardia. Longitudinal muscle can easily be dissected by
using a curved dissector. The inner circular muscle is
identified carefully and dissected from the mucosa by
blunt dissection. A modified Sugar Baker Pericardiomyo-
tomy Scissor is fashioned with a protective boot for pre-
venting mucosal injury. We have found it extremely con-
venient for carrying out the cardiomyotomy once the
correct plane is identified (Figure 3). The myotomy is
extended onto the proximal esophagus 2cm to 3cm above
the dilated portion and distally onto the stomach approx-
imately 0.5cm to 1cm. Extension beyond this increases the
incidence of reflux. Gastric myotomy is more difficult to
perform as the mucosa and outer muscular layers are
thinner and there are more bridging vessels than the
esophagus, which are highly prone to bleeding and per-
foration. In cases of perforation of the esophageal mu-
cosa, interrupted stitches with 4–0 Vicryl are used. A
myotomy of 0.5cm on the stomach is ideal.
Once the myotomy is completed, the muscular edges are
separated laterally for approximately 40% of the circum-
ference. If mucosal injury is suspected, a leak can be
Figure 1. Patient position and team position. A: Operating
surgeon. B: Assistant surgeons. C: Nursing assistant.
Figure 2. Port positions. Red: 10-mm ports. Green: 5-mm ports.
Midline supraumbilical port for camera; left hypochondrium port
for right-hand working; right hypochondrium port for left-hand
working; epigastric port for liver retraction; left anterior axillary
port for stomach retraction.
JSLS (2007)11:350–357 351checked for by instilling air into the esophagus while
submerging it in water used for irrigation.
If the hiatal opening is wide or crural division has been
performed to approach the esophagus in the mediasti-
num, crural repair is carried out using polypropelene 1–0
sutures.
After this, an antireflux procedure is performed, our
choice being either a modified Toupet fundoplication
(270
o posterior fundoplication, Figure 4) or a Dor fundo-
plication (180
o anterior fundoplication).
Postoperatively, a dye study using sodium meglumine
diatrizoate (Gastrografin) is conducted in select patients
after 24 hours to rule out a suspected mucosal leak. If the
mucosa is intact, the Ryles tube is removed, and the
patient is started on oral fluids, being discharged the next
day. Avoidance of extreme activity (eg, lifting and push-
ing) is advised for 1 month to prevent herniation of the
partial wrap through the mediastinum.
The patients were followed up by weekly attendance in
the outpatient department for 4 weeks followed by fort-
nightly visits until 12 weeks after surgery. At each visit, a
detailed history was obtained regarding the improvement
in the patient’s preoperative symptoms. A manometry was
performed on the 12th visit. If the manometry was satis-
factory, the patient was asked to attend the outpatient
department on an as needed basis.
RESULTS
Since 1993, 226 patients have been treated for achalasia
cardia with the laparoscopic method. The patient charac-
teristics are detailed in Table 1. Ten of our patients were
below the age of 14 years. Nearly half of our patients had
prior pneumatic dilatation on more than 2 occasions.
Seventy-five percent (84 patients) of these had early re-
currence of dysphagia within 4 weeks to 16 weeks, while
Figure 3. The cardiomyotomy being performed using the mod-
ified pericardiotomy scissors.
Figure 4. Toupet’s fundoplication.
Table 1.
Patient Characteristics
Age (years)
Range 6–85
Mean 36.4
Sex Distribution (M:F) 146:80
Presenting symptoms
Dysphagia 26 (100%)
Reflux of food in the mouth 184 (81.4%)
Heartburn 124 (54.9%)
Chest pain 84 (37.2%)
Respiratory complications 34 (15%)
Duration of symptoms
Range 2 mos to 3 years
Mean 1.4 years
Preoperative LES pressure (mm Hg)
Range 50–108
Mean 72
Prior pneumatic dilatation 112 patients
Minimally Invasive Management of Achalasia Cardia: Results From a Single Center Study, Palanivelu C et al.
JSLS (2007)11:350–357 352the remaining patients did not even have any temporary
relief of dysphagia after the dilatation. Around 15% of the
patients presented with respiratory complaints like chronic
cough, wheezing, asthma, and recurring pneumonia.
The operative details, morbidity, and mortality are
summarized in Table 2.
Anterior (Dor’s) wrap was performed in the early days of
our series. However, we found that Toupet’s wrap gives
better symptomatic relief against postoperative reflux
symptoms and now perform Dor’s wrap selectively in
patients with suspected mucosal injury.
The postoperative course is described in Table 3.
All the patients were successfully treated by laparoscopic
Heller’s myotomy with satisfactory relief of dysphagia. In
5 patients, mucosal injury was immediately noticed and
repaired by a laparoscopic hand-sewn technique using
4–0 polygalactin. Dor’s fundoplication was done in all
these patients to protect the suturing. There was difficulty
in mobilizing the esophagus, associated with periesoph-
ageal inflammation in 4 patients. In the patients who had
undergone previous dilatation, due to the fibrosis at the
cardia, dissection was difficult, especially in getting the
submucosal plane during myotomy.
One patient had dysphagia in the immediate postopera-
tive period. Endoscopy and barium meal study revealed a
paraesophageal hiatus hernia. Relaparoscopy done on the
fifth postoperative day confirmed the diagnosis. This pa-
tient had a long segment of hugely dilated esophagus. The
anterior cruciate ligament was divided to access the ante-
rior mediastinum so that the cardiomyotomy could be
carried out. However, at the end of the procedure, the
crura were not approximated. Reduction of the gastric
fundus and narrowing of the hiatus was done by approx-
imating the crura anteriorly with 1–0 prolene. This re-
lieved the dysphagia completely, and the patient has re-
mained symptom-free since then.
One patient had a bout of severe vomiting and retching on
the second postoperative day, 20 hours after resumption
of a liquid diet. Thereafter, the patient had a bout of
hematemesis. Careful endoscopy revealed a small Mal-
lory-Weiss tear in the lower esophagus. The patient was
managed conservatively with intravenous antibiotics and
hyperalimentation for one week. A water-soluble dye
study after one week revealed the absence of a leak, and
the patient made a subsequent uneventful recovery. We
advise all our patients to have a soft semi-solid diet for one
month. Postoperative dysphagia to solids was found in 10
patients (4.42%), who responded to conservative manage-
ment with continuance of a semi-solid diet for a period of
3 months postoperatively, at the end of which all patients
tolerated a normal diet.
Twelve weeks after surgery, 176 (79%) patients attended
follow-up and underwent manometry. There was com-
plete relief of achalasia by manometry in all these patients.
The remaining patients (n50) were contacted by tele-
phone and interviews were conducted. A further 14 pa-
tients complained of some degree of dysphagia, especially
to solids, bringing the total incidence of postoperative
dysphagia to 25 (11.1%). However, objective assessment
of their dysphagia by manometry could not be carried out.
DISCUSSION
Achalasia is a rare disease with an incidence of around 1
in 100 000 reported in the West.10 Achalasia is often not
Table 2.
Operative and Postoperative Details
Surgery Performed
Myotomy alone 20
Toupet 162
Dor 44
Mean Operating Time (minutes)
After endoscopic dilatation 108
Without endoscopic dilatation 82
Overall 96
Hospital Stay (days)
Range 2–10
Mean 2.2
Table 3.
Postoperative Course
Postoperative Relief of Dysphagia 201 (88.9%)
Follow-up
Range 1 mo–6 years
Mean 4.3 years
Morbidity 10 (4.4%)
Wound infection 3
Mucosal injury 5
Paraesophageal hiatus hernia 1
Mucosal blow-out 1
Mortality 0
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noted. Due to the slow progress of the disease, the symp-
toms are often confused with gastroesophageal reflux
disease or simple dyspepsia and treated accordingly. In
our series, the mean duration of symptoms was 1.4 years.
On the other hand, Wong et al11 reported a lag period of
2.6 years, and Arber12 reported a delay of 4.4 years in his
series, attributing it to the rarity of the disease. A patient
may present with a wide range of symptoms, depending
on the stage of disease at the time of diagnosis. Nearly all
of these complaints are related to the progressive obstruc-
tion of food and liquids at the gastroesophageal junction.
More than a third of our patients also presented with
atypical respiratory complaints. Similar presentations have
been documented in the literature.13,14 In addition, malig-
nant obstruction, gastroesophageal reflux disease stric-
ture, diffuse esophageal spasm, and nutcracker esophagus
can mimic achalasia.15,16
Various modalities of treatments have been advocated for
achalasia. Pharmacotherapy with nitrates and calcium-
channel blockers has limited value due to inconsistent and
short-lived action.17,18 With botulinum toxin, 50% of the
patients relapse within 1 year.19,20
Esophageal dilation affords substantial relief of dysphagia
after 1 year.21 However, repeated dilatation is often nec-
essary. Moreover, by 5 years, more than 50% of patients
have relapsed.22,23 Furthermore, several authorities have
confirmed the increased difficulty in performing cardiom-
yotomy in patients who have received botulinum toxin
injection or have undergone pneumatic dilatation.24–26
In a small sample of 12 patients, Dolan et al27reported a
slightly longer operative time in patients who had under-
gone previous pneumatic dilatation compared with those
who had not but found that no difference existed in the
complication rate or in clinical outcome between the 2
groups. Since the performance of the first laparoscopic
cardiomyotomy in 1991, several large series have proven
the efficacy of this approach.8,28,29 As compared with open
surgery, laparoscopic Heller myotomy has comparable
success rates with less early impairment to quality of life,
especially in terms of physical functioning and pain.30
Moreover, the open approach entails a perioperative mor-
tality of 1.2%, and the laparoscopic approach consistently
achieves a zero mortality rate.31 Thoracoscopic cardiom-
yotomy was reported by Pellegrini in 1992, followed by
several series.32–34 However, the laparoscopic approach
has proved to be more popular with the disadvantages of
thoracoscopy being a high rate of persistent dysphagia,
secondary GERD, greater postoperative pain, and longer
hospital stay.35,36
Technical difficulties include the necessity of working
orthogonal to the longitudinal axis of the esophagus,
inability to determine the exact length of myotomy on to
the cardia exactly, inability to visualize the gastroesopha-
geal junction, necessity of performing the surgery with the
patient in the lateral decubitus position with double-lu-
men tube anesthesia, and placement of a chest drainage
tube, which prolongs the operative time.37,38 A conten-
tious issue has been the necessity of adding an antireflux
procedure. In a retrospective review of 95 patients who
underwent a laparoscopic Heller myotomy without an
antireflux procedure, dysphagia was reported in an unac-
ceptably high number of 14% of patients.9
In contrast, Gupta et al39 reported good outcomes with
laparoscopic cardiomyotomy alone, with a low incidence
of postoperative dysphagia and heartburn. In a meta-
analysis of laparoscopic cardiomyotomy with or without
fundoplication from 1991 to 2001, the data of 532 patients
from 15 studies were analyzed. The difference in the rate
of gastroesophageal reflux diagnosed in postmyotomy pH
studies in wrapped and nonwrapped patients was not
significant (7.9% vs. 10%, respectively; P0.75). Also no
significant difference existed in the incidence of postmyo-
tomy GER symptoms in wrapped and nonwrapped pa-
tients (5.9% vs. 13% respectively; P0.12).40 Bloomston et
al41 selectively applied fundoplication in 21 of 100 patients
undergoing laparoscopic Heller myotomy. Preoperative
symptoms were similar for both groups of patients who
had significant improvement following myotomy with or
without fundoplication. In addition, no significant differ-
ences occurred in postoperative dysphagia or heartburn.
Overall improvement was seen in 86% of patients under-
going myotomy with fundoplication and in 97% without
fundoplication. Based on their experience, the authors
recommended selective application of fundoplication dur-
ing laparoscopic Heller myotomy for optimal outcomes.
Thus, some authors still do not recommend adding an
antireflux procedure to cardiomyotomy.9,42
However, pathologic gastroesophageal reflux can occur
in more than 50% of cases when a long myotomy (2c m
on the anterior gastric wall) has been carried out.43–45
Given the concern of postoperative reflux and the relative
ease of adding an antireflux procedure, it seems prudent
and reasonable to propose that all laparoscopic Heller
cardiomyotomies should be accompanied by an antireflux
procedure.46 Yet, more controversy surrounds the choice
of wrap-Dor or Toupet. The advantages of the Toupet
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myotomy and may be better than an anterior fundoplica-
tion in preventing postoperative GERD. On the other
hand, proponents of Dor’s fundoplication procedure ar-
gue that it is easy to perform, protects the anterior esoph-
agus following myotomy and leaves the posterior anat-
omy intact. Moreover, it has been suggested that a Toupet
procedure may increase the incidence of postoperative
reflux secondary to retroesophageal dissection, and in-
crease the likelihood of postoperative dysphagia due to
angulation of the posterior esophagus. Balaji et al,47 while
reporting a multiinstitutional comparison of different fun-
doplication techniques, suggested that the Dor anterior
fundoplication was associated with less heartburn and a
decreased prevalence of persistent dysphagia.
Oelschlager et al48 compared Dor versus Toupet fundo-
plication along with an extended myotomy with the latter
and found a higher incidence of postoperative dysphagia
with Dor’s fundoplication and suggested that this was due
to the covering of the myotomy site with the wrap, which
could lead to adhesion formation and recurrent obstruc-
tion. On the other hand, Hunter et al49 found no symp-
tomatic reflux difference in patients who underwent either
of the two wraps. In the absence of randomized trials
comparing the 2 wraps, the choice of the antireflux pro-
cedure will remain a moot issue. Recently, Rossetti et al50
reported excellent results with a total fundoplication (360-
degree Nissen Rossetti wrap) with no chemical reflux and
2.2% persistence of dysphagia on long-term follow-up.
Though initially we preferred the Dor wrap because of its
technical ease, we now almost exclusively perform the
Toupet wrap unless there is a suspicion of mucosal injury.
Postoperative dysphagia was found in 11.1% of our pa-
tients, all of whom responded to conservative manage-
ment. The incidence of this complication in the literature
varies from 3.4% to 17% when a long cardiomyotomy and
an antireflux procedure have been performed.51–54 The
mucosal injury rate in our series was 2.2%, all the patients
having had at least 2 prior sessions of pneumatic dilata-
tion. Dissection was difficult in the submucosal plane in
all the 5 patients due to fibrosis. The injury was recog-
nized intraoperatively and repaired in all patients fol-
lowed by a Dor fundoplication. None of these patients
had any subsequent morbidity. Mucosal tear rates re-
ported in literature vary from 4% to 14%.41,52,54,55 We have
found the modified pericardiotomy scissors with an insu-
lated protective boot very useful for safe and hemostatic
division of the muscle fibers. Once the correct submucosal
plane is obtained by blunt separation of the overlying
muscle fibers, it is a simple matter to insert the pericar-
diotomy scissors and further extend the myotomy. Its
rounded blunt tip gently strips the mucosal from the
muscular layer, and the protective boot shields the mu-
cosa while the muscle can be cauterized and cut.
Taskin et al56 reported intraoperative balloon-dilatation
assisted cardiomyotomy, claiming that balloon dilation
makes myotomy easier because it separates the muscle
fibers. Robotic surgery has already been adapted for this
procedure. The main advantages of robot-assisted laparo-
scopic surgery are the availability of 3-dimensional vision
and easier instrument manipulation than can be obtained
with standard laparoscopy. Disadvantages include the
large diameter of the instruments (8mm) and the limited
number of robotic arms (maximum, 3). The learning curve
to master the robot was performance of 10 or more robotic
procedures. In addition, in contrast to human operators,
robots can malfunction necessitating conversion.57–59
CONCLUSION
Our preferred approach for esophageal achalasia is a
laparoscopic Heller myotomy and partial Toupet fundo-
plication. We have found the modified pericardiotomy
scissors very useful for rapid, safe, and hemostatic division
of muscle fibers, as borne out by the low incidence of
mucosal injury in our series. This has been found to be
effective in relieving dysphagia and has a low incidence of
postoperative reflux. In our series, we have found the
laparoscopic approach to be associated with low morbid-
ity, nil mortality, and a short hospital stay. We found it to
provide satisfactory symptomatic relief and consider it the
treatment of choice for this disabling disease.
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